Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.5980
+0.0336 (5.95%)
At close: Jan 21, 2026, 4:00 PM EST
0.6200
+0.0220 (3.68%)
After-hours: Jan 21, 2026, 7:18 PM EST
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $29.03 million as of January 21, 2026. Its market cap has decreased by -58.25% in one year.
Market Cap
29.03M
Enterprise Value
227.72K
1-Year Change
-58.25%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $29.03M, a decrease of -93.41%. That is a compound annual growth rate of -43.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 27.40M | -10.91% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | 440.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |